FINWIRES · TerminalLIVE
FINWIRES

Ollie's Bargain Outlet Delivers Q2 Earnings Beat Amid Tough Macro Environment, BofA Securities Says

By

Ollie's Bargain Outlet (OLLI) reported fiscal Q2 earnings above consensus, but the outlook remains cautious given a tougher macro environment and the fading benefit of tariff refunds, BofA Securities said in a note Thursday.

The company's fiscal Q2 beat was driven by gross margin expansion from tariff refunds, which helped offset weaker sales, analysts said. Sales were pressured by smaller baskets, while transactions were flat. Unfavorable weather hurt traffic and spending early in the quarter, but both improved as the quarter progressed, according to the note.

Analysts said they are raising their fiscal 2026 EPS estimate by 2% to $4.62 to reflect the Q2 beat, partly offset by lower sales and margin outlook for H2. They lowered their fiscal 2027 EPS estimate by 2% to $4.98 because Ollie's will no longer benefit from tariff refunds.

"As inflation persists, we think that Ollie's will benefit from trade-down and become more important to its core customer looking to stretch a dollar," analysts said.

BofA lowered its price target on Ollie's Bargain Outlet to $105 from $115, while reiterating its buy rating.

Shares of the company were down more than 3% in Thursday trading.

Price: $71.36, Change: $-2.52, Percent Change: -3.40%

Related Articles

Wire

Ionic Rare Earths Strikes Magnet Recycling Joint Venture Agreement With US Strategic Metals; Shares Rise 10%

Ionic Rare Earths (ASX:IXR) unit Ionic Rare Earths USA struck a joint venture agreement with US Strategic Metals to build magnet recycling facilities at the latter's fully permitted site in Missouri, US, according to a Thursday filing with the Australian bourse.The new term sheet supersedes and "materially advance" the memorandum of understanding the parties struck in November 2025, per the filing.The parties agreed on a non-binding basis to form a 50-50 joint venture to develop an integrated campus for the production of critical minerals and metals at the Missouri site. The proposed joint venture aims to construct one or more magnet and other rare earth recycling facilities, processing recycled permanent neodymium-iron-boron and samarium-cobalt magnets and magnet scrap, and also plans to evaluate the recycling of other heavy rare earth elements.Ionic Rare Earths' Belfast subsidiary, Ionic Technologies, will contribute a non-exclusive license to the joint venture for its magnet recycling technology.The planned venture will be funded with $100 million for the construction of initial recycling facilities, comprised of $95 million in funding from US Strategic Metals and a $5 million equity contribution split equally between Ionic Rare Earths USA and US Strategic Metals.Ionic Rare Earths shares jumped over 10% in recent Thursday trade.

ASX:IXR
Wire

Ultragenyx Says Phase 3 Study on Rare Neurogenetic Disorder Missed Primary, Secondary Endpoints; Shares Fall After-Hours

Ultragenyx Pharmaceutical (RARE) said late Wednesday the phase 3 Aspire study of apazunersen in Angelman syndrome, a rare, neurogenetic disorder, did not achieve its primary endpoint or its key secondary endpoint.The late-stage study did not reach the primary endpoint of change from Baseline in Bayley-4 cognitive raw score nor the key secondary endpoint of net response in Multidomain Responder Index, according to a statement.The safety profile for the phase 3 trial remained consistent with phase 1 and phase 2, the company said.Ultragenyx said it will assess the apazunersen program following this outcome and make a decision on its disposition.Shares of Ultragenyx were down about 45% in after-hours trading.

$RARE
Wire

ChargePoint Q2 Loss Narrows, Revenue Rises

ChargePoint (CHPT) reported Wednesday Q2 loss of $1.35 per diluted share, compared with a loss of $2.85 a year earlier.Analysts polled by FactSet expected loss of $1.57.Revenue for the quarter ended July 31 was $116.1 million, up from $98.6 million a year ago.Analysts expected $105.2 million.ChargePoint expects Q3 revenue of $105 million to $115 million. Analysts expect $109.3 million.Shares of the company rose over 17% in after-hours trading.

$CHPT